Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma	B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1 / Phase 2	2025-08-24		NCT05607420

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cellectis S.A.	3

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Saint-Louis - Centre Integre en Cancerologie	Paris	France	1
Centre Hospitalier Universitaire de Montpellier (CHU Montpellier) - Hopital Saint-Eloi	Montpellier	France	1
Centre Hospitalier Universitaire de Nantes (CHU de Nantes)-Hotel-Dieu	Nantes	France	1
Harvard Medical School - Massachusetts General Hospital	Boston	United States	1
Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud	Pierre-Bénite	France	1
Hospital Universitario Virgen del Rocio (HUVR) - Instituto de Biomedicina de Sevilla (IBIS)	Seville	Spain	2
Rutgers Cancer Institute of New Jersey (CINJ) - New Brunswick	New Brunswick	United States	1
Sarah Cannon - St. David South Austin Medical Center	Austin	United States	1
The University of Chicago Medical Center (UCMC)	Chicago	United States	11
Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Pamplona	Pamplona	Spain	2